Development Level

Tbio 59 | 10,625
Tchem 43 | 1,890
Tdark 12 | 7,003
Tclin 5 | 602

Collection

Eligible Kinase Proteins 3 | 134
Eligible Ion Channel Proteins 1 | 117

IMPC Term

preweaning lethality, complete... 7 | 633
embryonic lethality prior to t... 6 | 187
embryonic lethality prior to o... 4 | 148
abnormal bone structure 3 | 131
decreased bone mineral content 3 | 157
increased mean corpuscular vol... 3 | 91
male infertility 3 | 62
abnormal embryo size 2 | 112
abnormal retina morphology 2 | 100
decreased lean body mass 2 | 195
increased bone mineral density 2 | 52
increased lean body mass 2 | 107
abnormal coat/hair pigmentatio... 1 | 54
abnormal forebrain development 1 | 18
abnormal hindbrain development 1 | 24
abnormal midbrain development 1 | 22
abnormal neural tube closure 1 | 37
abnormal retinal pigmentation 1 | 61
abnormal skin morphology 1 | 23
decreased body weight 1 | 174
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 49
decreased circulating alanine ... 1 | 53
decreased circulating aspartat... 1 | 27
decreased circulating bilirubi... 1 | 14
decreased circulating chloride... 1 | 32
decreased circulating glucose ... 1 | 121
decreased circulating magnesiu... 1 | 11
decreased circulating serum al... 1 | 79
decreased eosinophil cell numb... 1 | 41
decreased grip strength 1 | 123
decreased mean corpuscular hem... 1 | 34
decreased neutrophil cell numb... 1 | 37
decreased total body fat amoun... 1 | 186
embryonic growth retardation 1 | 28
enlarged lymph nodes 1 | 27
female infertility 1 | 34
hydrops fetalis 1 | 22
hypoactivity 1 | 89
improved glucose tolerance 1 | 56
increased bone mineral content 1 | 92
increased circulating alanine ... 1 | 11
increased circulating alkaline... 1 | 119
increased circulating glucose ... 1 | 16
increased exploration in new e... 1 | 56
increased grip strength 1 | 83
increased leukocyte cell numbe... 1 | 37
increased mean corpuscular hem... 1 | 93
increased neutrophil cell numb... 1 | 15
increased or absent threshold ... 1 | 128
preweaning lethality, incomple... 1 | 260
small epididymis 1 | 3
urinary bladder obstruction 1 | 2

Disease

ovarian cancer 68 | 8,484
medulloblastoma, large-cell 65 | 6,234
glioblastoma 57 | 5,572
psoriasis 53 | 6,685
osteosarcoma 52 | 7,933
atypical teratoid / rhabdoid tumor 45 | 4,369
primitive neuroectodermal tumor 39 | 3,031
Cancer 38 | 2,346
Breast cancer 37 | 3,094
lung cancer 36 | 4,466
intraductal papillary-mucinous neoplasm (IPMN) 34 | 3,289
lung adenocarcinoma 32 | 2,713
astrocytic glioma 31 | 2,241
pediatric high grade glioma 31 | 2,712
intraductal papillary-mucinous carcinoma (IPMC) 30 | 2,988
malignant mesothelioma 30 | 3,162
oligodendroglioma 27 | 2,849
pilocytic astrocytoma 27 | 3,086
non-small cell lung cancer 26 | 2,798
ependymoma 25 | 2,514
invasive ductal carcinoma 25 | 2,950
adult high grade glioma 22 | 2,148
colon cancer 21 | 1,475
group 3 medulloblastoma 21 | 2,254
adrenocortical carcinoma 20 | 1,427
intraductal papillary-mucinous adenoma (IPMA) 20 | 2,956
Carcinoma 19 | 2,147
Pick disease 19 | 1,893
medulloblastoma 19 | 1,524
breast carcinoma 18 | 1,614
pancreatic cancer 18 | 2,300
subependymal giant cell astrocytoma 18 | 2,287
ductal carcinoma in situ 16 | 1,745
posterior fossa group A ependymoma 16 | 1,511
Atopic dermatitis 15 | 944
atypical teratoid/rhabdoid tumor 15 | 1,095
interstitial cystitis 15 | 2,299
sonic hedgehog group medulloblastoma 15 | 1,482
Endometriosis 14 | 535
Waldenstrons macroglobulinemia 14 | 765
lung carcinoma 14 | 2,844
group 4 medulloblastoma 13 | 1,875
ulcerative colitis 13 | 2,087
Multiple myeloma 12 | 1,327
IGA Glomerulonephritis 11 | 454
dermatomyositis 11 | 933
nasopharyngeal carcinoma 11 | 1,056
pituitary cancer 11 | 1,972
Obesity 10 | 616
acute quadriplegic myopathy 10 | 1,157
astrocytoma 10 | 1,493
diabetes mellitus 10 | 1,663
juvenile dermatomyositis 10 | 1,189
pancreatic ductal adenocarcinoma liver metastasis 10 | 1,795
Prostatic Neoplasms 9 | 471
Rheumatoid Arthritis 9 | 1,160
esophageal adenocarcinoma 9 | 737
primary Sjogren syndrome 9 | 789
primary pancreatic ductal adenocarcinoma 8 | 1,271
spina bifida 8 | 1,064
Acquired metabolic disease 7 | 267
Alzheimer's disease 7 | 644
Amyotrophic Lateral Sclerosis 7 | 431
Intellectual disability 7 | 573
Polycystic Ovary Syndrome 7 | 332
cutaneous lupus erythematosus 7 | 1,056
posterior fossa group B ependymoma 7 | 1,530
Infertility 6 | 163
Mammary Neoplasms 6 | 410
Schizophrenia 6 | 501
active Crohn's disease 6 | 918
cystic fibrosis 6 | 1,665
progressive supranuclear palsy 6 | 674
Bladder Neoplasm 5 | 109
Crohn's disease 5 | 304
Mammary Neoplasms, Experimental 5 | 150
Melanoma 5 | 261
Neoplasm Metastasis 5 | 138
Parkinson's disease 5 | 364
aldosterone-producing adenoma 5 | 664
inflammatory breast cancer 5 | 404
Asthma 4 | 349
Autistic Disorder 4 | 320
Cocaine-Related Disorders 4 | 88
Heart disease 4 | 279
Hyperalgesia 4 | 71
Hypertensive disease 4 | 193
Liver carcinoma 4 | 217
Male infertility 4 | 170
Myocardial Ischemia 4 | 169
Osteoporosis 4 | 257
Peripheral Neuropathy 4 | 303
Vascular disease 4 | 281
acute myeloid leukemia 4 | 780
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | 499
gastric carcinoma 4 | 832
hereditary spastic paraplegia 4 | 313
tuberculosis 4 | 1,557
tuberculosis and treatment for 3 months 4 | 327
tuberculosis and treatment for 6 months 4 | 686

Tissue

Blood and immune system 117 | 17,995
Endocrine System 117 | 18,512
Female tissues 117 | 18,647
Liver and Pancreas 117 | 18,136
Nervous System 117 | 18,561
Skin and soft tissues 117 | 18,115
Urinary Tract 117 | 18,444
Cardiovascular System 116 | 17,958
Digestive Tract 116 | 18,473
Male tissues 115 | 17,969
Respiratory system 115 | 17,484

Target Family

Non-IDG 52 | 11,971
Enzyme 38 | 4,146
Kinase 24 | 634
Ion Channel 3 | 341
Nuclear Receptor 2 | 48

KEGG Pathway

Oocyte meiosis 119 | 119
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
G2/mitotic-specific cyclin-B1 CCNB1 Tchem Non-IDG -3.09727 1121.4 955
Putative speedy protein E6 SPDYE6 Tdark Non-IDG 0.00000 0
Cytoplasmic polyadenylation element-binding protein 1 CPEB1 Tbio Non-IDG -2.20580 171.1 185
Calcium/calmodulin-dependent protein kinase type II subunit alpha CAMK2A Tchem Kinase -1.76384 47.5 542
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Cytoplasmic polyadenylation element-binding protein 3 CPEB3 Tbio Non-IDG -1.28920 20.4 75
Structural maintenance of chromosomes protein 1B SMC1B Tbio Non-IDG -1.26509 19.6 93
Adenylate cyclase type 1 ADCY1 Tchem Enzyme -1.58202 42.2 123
Shugoshin 1 SGO1 Tbio Non-IDG -2.38169 259.7 124
Speedy protein E1 SPDYE1 Tdark Non-IDG 1.75 69